New guideline spells out IPMN essentials

It was a call he dreaded making. It was the late 1990s. Volkan Adsay, MD, was following up on a former patient who had been diagnosed eight years earlier with pancreatic cancer, one related to an intraductal papillary mucinous neoplasm. The patient’s medical record noted that despite chemotherapy, the prognosis was grim.

Read the full story »

Dr. Volkan Adsay (right), with coauthors
and Emory pathologists Alyssa Krasinskas, MD
(front), and Michelle Reid, MD.

Upper-echelon QA through Accuracy-Based Programs

HbA1c, creatinine, testosterone, vitamin D, lipids, and maybe albumin. If you know what the common thread is among these analytes, then you may be familiar with the CAP’s Accuracy-Based Programs and their evolution over the past couple of decades. While a few providers around the world offer accuracy-based surveys, the College’s Accuracy-Based Programs are by far the largest.

Read the full story »

John H. Eckfeldt, MD, PhD

For viral diagnosis,
metagenomic NGS

A 20-year-old woman who had returned to the U.S. after two months of hiking in Western Australia presented with three days of acute febrile illness—fever, rash, headache, nausea, and muscle and joint pain. Testing for common infectious causes of acute febrile illness, including Epstein-Barr virus, cytomegalovirus, and human immunodeficiency virus, all turned up negative.

Read the full story »

Charles Chiu, MD, PhD

Visuals to the fore in new histology labeling guideline

Like laboratorians, filmmakers split their workflow into three phases. In film, they are pre-production, production, and post-production. When flubs occur on a movie set, “We’ll fix it in post,” often said sardonically, is the fallback game plan to keep things on schedule and use visual and sound effects to cover up mistakes.

Read the full story »

Richard W. Brown, MD

June 2015 Issue

New guideline spells out IPMN essentials | Upper-echelon QA through Accuracy-Based Programs | For viral diagnosis, metagenomic NGS

Interactive Product Guides

Recently updated: In Vitro Blood Gas Analyzers | Laboratory-Provider Links Software | Coagulation analyzers—Point of Care, Self-Monitoring |

Past Articles

Advances in tests and equipment, trends in management and clinical operation, regulatory changes, finance, and more.

Past Departments

The President’s Desk, Q & A, Clinical, Anatomic, and Molecular abstracts, Newsbytes, Put it on the Board, Shorts on Standards, People, and Letters.

Marketplace

New pathology lab products and industry news from dozens of companies.

Quick Links

CAP TODAY Hosted Webinars
Interactive product guides
Download product guide PDFs
Subscribe or renew CAP TODAY
grayline_light

Archives of Pathology & Laboratory Medicine

Web-Only Content:
Abstracts and Case Studies from CAP ’14.

Early Online Release:
Uniform Labeling of Blocks and Slides in Surgical Pathology: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center and the National Society for Histotechnology

grayline_light

ATHENA trial—an interview with Thomas Lorey, MD

The Food and Drug Administration on April 24 approved use of the Roche Cobas HPV test as a primary standalone screen for cervical cancer in women 25 and older. For a discussion of the ATHENA data on which the FDA based its decision, see Dr. Check’s June story “Data spark new directions in cervical cancer.”

Archives: HPV primary screening for cervial cancer—an interview with Ritu Nayar, MD.

Laboratorian Career Center

Search for jobs or post open positions for pathology-related jobs. Start here.grayline_light

CAP TODAY Recommends

Labs need to evolve at the speed of healthcare

This editorial is brought to you through Roche’s Lab Leaders initiative.

AMP sees bright future for liquid biopsy

May 20, 2015—The Association for Molecular Pathology recently published a special article that provides a thorough overview of research to date on the minimally invasive “liquid biopsy” approaches to cancer diagnostics. Read it.

How breath tests can diagnose liver diseases

May 20, 2015—In a recent interview, Exalenz Bioscience CEO Larry Cohen discussed his company’s innovations in testing for H. Pylori and clinically significant portal hypertension with its BreathID test. Read it.

Primer for patients on breast biopsies

April 9, 2015—In a recent video, pathologist Michael J. Misialek, MD, offered some clinical practice insights geared to patients concerned about the recent JAMA study on the accuracy of breast biopsies. Watch.

Roundtable discussions 2015:
The future of the lab in health care

April 6, 2015—In a collaborative effort to discuss the future of the laboratory in healthcare, Bob McGonnagle, Publisher of CAP Today, gathered with Orchard Software executives for a series of “round table discussions” on various topics surrounding the laboratory, informatics, analytics, and the future of healthcare. Listen now.

Consensus offered on IPMNs

March 24, 2015—An international multidisciplinary group has published consensus guidelines on the pathologic diagnosis and reporting of intraductal papillary mucinous neoplasms. More

More CAP TODAY Recommends